Department of Health and Human Services · UII 009-000402093
FDA CDER OTS Product Review & Approval
CIO Rating
4 - Moderately Low Risk
FY2025 Funding (PY)
$14.7M
Recompete
Low
Active Contracts
20
Recompete Signal
Recompete Probability: Low
No near-term contract end with BY funding and no sustained CIO trouble.
CIO Rating Trend
4
May '24
4-5 Low Risk3 Medium Risk1-2 High RiskNot Rated
Funding Trend
$14.0M
FY2020
PY$14.7M
FY2021
PY$18.3M
FY2022
PY$20.5M
FY2023
PY$15.1M
FY2024
PY$14.7M
FY2025
PYInternal funding (agency's own budget)Contribution (working-capital / inter-agency)CY = current year · BY = budget year (projected) · PY = prior year
Cost Pool Breakdown
Where the FY2025 spend went, broken down by category.
Hardware
$800K
Internal Labor
$290K
External Labor
$33K
Software
$25K
Active Contracts
| Prime | PIID | Amount | PoP Start | PoP End |
|---|---|---|---|---|
| — | FDAHHS75F40122S10021 | — | — | — |
| — | 75F40122F80456 | — | — | — |
| — | 75F40122F19007 | — | — | — |
| — | 75F40121F80273 | — | — | — |
| — | 75F40122F80228 | — | — | — |
| — | 75F40122F80451 | — | — | — |
| — | 75F40122F80372 | — | — | — |
| — | 75F40122F80455 | — | — | — |
| — | 75F40120F19008 | — | — | — |
| — | 75F40121F19016 | — | — | — |
| — | 75F40119F19001 | — | — | — |
| — | 75F40123F80142 | — | — | — |
| — | 75F40123C00041 | — | — | — |
| — | 75F40123F19009 | — | — | — |
| — | 75F40123F80355 | — | — | — |
| — | 75F40123F19012 | — | — | — |
| — | 75F40123F19006 | — | — | — |
| — | 75F40123F19035 | — | — | — |
| — | 75F40124F80102 | — | — | — |
| — | 75F40121D00014 | — | — | — |
Get the AI Pursuit Report for "FDA CDER OTS Product Review & Approval"
Strategic interpretation, personalized fit score (NAICS + certs + past performance), incumbent analysis, and win-themes recommendations. ~6-8 page PDF, generated in 30 seconds.
$49 per report
Or included in Pro ($799/mo, 25 reports/month) and Enterprise (unlimited)